Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-03-01 @ 11:27 AM
Study NCT ID:
NCT02682420
Status:
TERMINATED
Last Update Posted:
2025-12-11
First Post:
2016-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
everlinQ endoAVF Post Market Study
Sponsor:
C. R. Bard
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Kidney Disease | View |
Keywords: